200 related articles for article (PubMed ID: 21535479)
1. An evaluation of the Sebia capillarys Neonat Haemoglobin FAST™ system for routine newborn screening for sickle cell disease.
Murray C; Hall SK; Griffiths P
Int J Lab Hematol; 2011 Oct; 33(5):533-9. PubMed ID: 21535479
[TBL] [Abstract][Full Text] [Related]
2. Potential of the Sebia Capillarys neonat fast automated system for neonatal screening of sickle cell disease.
Renom G; Mereau C; Maboudou P; Périni JM
Clin Chem Lab Med; 2009; 47(11):1423-32. PubMed ID: 19912048
[TBL] [Abstract][Full Text] [Related]
3. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for hemoglobinopathies using capillary electrophoresis technology: Testing the Capillarys Neonat Fast Hb device.
Mantikou E; Harteveld CL; Giordano PC
Clin Biochem; 2010 Nov; 43(16-17):1345-50. PubMed ID: 20621075
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two methods for the quantification and identification of hemoglobin variants.
Higgins T; Mack M; Khajuria A
Clin Biochem; 2009 May; 42(7-8):701-5. PubMed ID: 19318037
[TBL] [Abstract][Full Text] [Related]
6. Screening for haemoglobinopathies on cord blood: laboratory and clinical experience.
Wolff F; Cotton F; Gulbis B
J Med Screen; 2012 Sep; 19(3):116-22. PubMed ID: 23093729
[TBL] [Abstract][Full Text] [Related]
7. Implementing neonatal screening for haemoglobinopathies in the Netherlands.
Bouva MJ; Mohrmann K; Brinkman HB; Kemper-Proper EA; Elvers B; Loeber JG; Verheul FE; Giordano PC
J Med Screen; 2010; 17(2):58-65. PubMed ID: 20660432
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies.
Greene DN; Pyle AL; Chang JS; Hoke C; Lorey T
Clin Chim Acta; 2012 Aug; 413(15-16):1232-8. PubMed ID: 22515960
[TBL] [Abstract][Full Text] [Related]
9. Screening for intermediate and severe forms of thalassaemia in discarded red blood cells: optimization and feasibility.
George E; Lai MI; Teh LK; Ramasamy R; Goh EH; Asokan K; Tan JA; Vasudevan M; Low S
Med J Malaysia; 2011 Dec; 66(5):429-34. PubMed ID: 22390095
[TBL] [Abstract][Full Text] [Related]
10. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
[TBL] [Abstract][Full Text] [Related]
11. Quantification of HbA(2) in patients with and without beta-thalassemia and in the presence of HbS, HbC, HbE, and HbD Punjab hemoglobin variants: comparison of two systems.
Higgins TN; Khajuria A; Mack M
Am J Clin Pathol; 2009 Mar; 131(3):357-62. PubMed ID: 19233839
[TBL] [Abstract][Full Text] [Related]
12. Neonatal screening for sickle cell disease in France.
Bardakdjian-Michau J; Bahuau M; Hurtrel D; Godart C; Riou J; Mathis M; Goossens M; Badens C; Ducrocq R; Elion J; Perini JM
J Clin Pathol; 2009 Jan; 62(1):31-3. PubMed ID: 19103855
[TBL] [Abstract][Full Text] [Related]
13. Analytical evaluation of the Capillarys 2 Flex piercing for routine haemoglobinopathies diagnosis.
Agouti I; Merono F; Bonello-Palot N; Badens C
Int J Lab Hematol; 2013 Apr; 35(2):217-21. PubMed ID: 22943067
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Sebia Minicap Flex Piercing capillary electrophoresis for hemoglobinopathy testing.
Oyaert M; Van Laer C; Claerhout H; Vermeersch P; Desmet K; Pauwels S; Kieffer D
Int J Lab Hematol; 2015 Jun; 37(3):420-5. PubMed ID: 25324031
[TBL] [Abstract][Full Text] [Related]
15. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies.
Keren DF; Hedstrom D; Gulbranson R; Ou CN; Bak R
Am J Clin Pathol; 2008 Nov; 130(5):824-31. PubMed ID: 18854277
[TBL] [Abstract][Full Text] [Related]
17. MALDI-TOF MS profiling as the first-tier screen for sickle cell disease in neonates: matching throughput to objectives.
Hachani J; Duban-Deweer S; Pottiez G; Renom G; Flahaut C; Périni JM
Proteomics Clin Appl; 2011 Aug; 5(7-8):405-14. PubMed ID: 21751410
[TBL] [Abstract][Full Text] [Related]
18. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for sickling and other haemoglobin disorders using tandem mass spectrometry: A pilot study of methodology in laboratories in England.
Daniel YA; Henthorn J
J Med Screen; 2016 Dec; 23(4):175-178. PubMed ID: 26965059
[TBL] [Abstract][Full Text] [Related]
20. Reliability of the current newborn screening action value for beta thalassaemia disease detection in England: A prospective study.
Daniel Y; Henthorn J
J Med Screen; 2019 Jun; 26(2):67-70. PubMed ID: 30249157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
